POSC4 Modeling Health-Related Outcomes With Avelumab as a First-Line Maintenance Treatment Following Chemotherapy vs. Best Supportive Care (BSC) for Patients With Locally Advanced or Metastatic Urothelial Cancer in the UK
Abstract
Authors
S Critchlow Y Xiao S Crabb A Eccleston K Christoforou A Amin A Bullement K Deighton J Chang M Kearney V Kapetanakis Á Benedict